About Hikma
Hikma develops, manufactures and markets generic medicines. The group describes operations in North America, Europe, the Middle East and North Africa.
Its presentation includes injectable medicines and the needs of healthcare facilities. The business combines manufacturing capabilities with distribution operations across several markets.
Official sources
- Hikma
- Hikma — activité française d’exploitant de spécialités injectables
- Hikma — implantation Hikma France SAS
- ANSM/BDPM — ADENOSINE HIKMA 6 mg/2 mL, exploitant Hikma France
Information checked 10 November 2026
Logo sourceAssociated catalogue products
7 references
These products are linked to this organisation in the catalogue as a laboratory or supplier. Refer to each product page for its documented manufacturer or operator. Purchasing terms and ordering are available through your professional account.
- Hikma France
FLUMAZENIL HIKMA 0,1 mg/ml Solution for IV infusion 5Ampoule/5ml
CIP / EAN : 3400930161081
- Hikma France
GEMCITABINE HIKMA 38 mg/ml for dilution and infusion bottle/26,3 ml
CIP / EAN : 3400955074212
- Hikma France
LEVETIRACETAM HIKMA 100 mg/ml Solution for infusion dilution 10Vial/5ml
CIP / EAN : 3400930116913
Your professional shop
Open the shop to sign in, view the terms available to your account and place your order.
Open the shop